Orexigen Therapeutics (NASDAQ:OREX) last issued its quarterly earnings data on Wednesday, May 4th. The biopharmaceutical company reported ($0.15) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.17) by $0.02. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. The business earned $5 million during the quarter, compared to analyst estimates of $7.78 million.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.